Related Experiment Video
Updated: Aug 25, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets
James D Johnson1, Zhiqiang Han, Kenichi Otani
1Department of Internal Medicine, Washington University, St. Louis, Missouri 63110, USA.
Abstract:
Cells are programmed to die when critical signaling and metabolic pathways are disrupted. Inhibiting the type 2 ryanodine receptor (RyR2) in human and mouse pancreatic beta-cells markedly increased apoptosis. This mode of programmed cell death was not associated with robust caspase-3 activation prompting a search for an alternative mechanism. Increased calpain activity and calpain gene expression suggested a role for a calpain-dependent death pathway. Using a combination of pharmacological and genetic approaches, we demonstrated that the calpain-10 isoform mediated ryanodine-induced apoptosis. Apoptosis induced by the fatty acid palmitate and by low glucose also required calpain-10. Ryanodine-induced calpain activation and apoptosis were reversed by glucagon-like peptide or short-term exposure to high glucose. Thus RyR2 activity seems to play an essential role in beta-cell survival in vitro by suppressing a death pathway mediated by calpain-10, a type 2 diabetes susceptibility gene with previously unknown function.
Insights
Inhibiting the type 2 ryanodine receptor (RyR2) in pancreatic beta-cells increased apoptosis via calpain-10, a type 2 diabetes gene. RyR2 activity suppresses this cell death pathway, crucial for beta-cell survival.
Area of Science:
- Cell Biology
- Endocrinology
- Molecular Biology
Background:
- Cellular apoptosis is triggered by disruptions in signaling and metabolic pathways.
- The type 2 ryanodine receptor (RyR2) is implicated in cellular survival mechanisms.
Purpose of the Study:
- To investigate the mechanism of apoptosis induced by RyR2 inhibition in pancreatic beta-cells.
- To identify the specific pathways and molecules involved in this programmed cell death.
Main Methods:
- Utilized pharmacological and genetic approaches to inhibit RyR2 in human and mouse pancreatic beta-cells.
- Assessed apoptosis, caspase-3 activation, and calpain activity and expression.
- Investigated the role of calpain-10 isoform in ryanodine-induced apoptosis.
Main Results:
- Inhibition of RyR2 markedly increased apoptosis in pancreatic beta-cells, independent of caspase-3.
- Increased calpain activity and gene expression suggested a calpain-dependent pathway.
- Calpain-10 was identified as the mediator of ryanodine-induced apoptosis.
- Apoptosis induced by palmitate and low glucose also required calpain-10.
- Ryanodine-induced apoptosis was reversed by glucagon-like peptide or high glucose.
Conclusions:
- RyR2 activity is essential for beta-cell survival in vitro by suppressing a calpain-10-mediated death pathway.
- Calpain-10, a type 2 diabetes susceptibility gene, plays a critical role in beta-cell apoptosis.
- Modulating RyR2 activity or calpain-10 could offer therapeutic strategies for diabetes.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Acute Pancreatitis II: Pathophysiology
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...

